Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

NCT00567099 is registered in ClinicalTrials.gov with New Mexico VA Healthcare System as lead sponsor.

NCT NCT00567099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Lead sponsor
New Mexico VA Healthcare System
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2003
Completion date
September 30, 2008
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, sensory gating